End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
123.8 CLP | 0.00% | 0.00% | -5.53% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 85.02 | 62.21 | 65.66 | 31.97 | 47.69 | 46.39 |
Enterprise Value (EV) 1 | 315.1 | 400.1 | 380.4 | 355.7 | 216.5 | 210.8 |
P/E ratio | 49 x | -15.5 x | -7.33 x | 10.3 x | 1.19 x | -2.96 x |
Yield | 0.61% | - | - | 2.92% | 25.2% | - |
Capitalization / Revenue | 0.21 x | 0.19 x | 0.19 x | 0.09 x | 0.1 x | 0.12 x |
EV / Revenue | 0.77 x | 1.25 x | 1.08 x | 0.99 x | 0.44 x | 0.56 x |
EV / EBITDA | 6.44 x | 115 x | -50.4 x | 19.2 x | 2.42 x | 115 x |
EV / FCF | 45.9 x | -3.75 x | 10.5 x | 1,752 x | 3.4 x | 5.04 x |
FCF Yield | 2.18% | -26.6% | 9.54% | 0.06% | 29.4% | 19.8% |
Price to Book | 0.35 x | 0.27 x | 0.3 x | 0.15 x | 0.19 x | 0.2 x |
Nbr of stocks (in thousands) | 310,907 | 310,907 | 310,907 | 310,907 | 310,907 | 310,907 |
Reference price 2 | 0.2734 | 0.2001 | 0.2112 | 0.1028 | 0.1534 | 0.1492 |
Announcement Date | 08/03/19 | 05/03/20 | 10/03/21 | 05/03/22 | 04/03/23 | 08/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 411.5 | 320.9 | 353.8 | 357.9 | 487.5 | 379.5 |
EBITDA 1 | 48.93 | 3.492 | -7.549 | 18.52 | 89.41 | 1.832 |
EBIT 1 | 18.88 | -27.6 | -38.06 | -4.532 | 70.92 | -13.3 |
Operating Margin | 4.59% | -8.6% | -10.76% | -1.27% | 14.55% | -3.51% |
Earnings before Tax (EBT) 1 | 8.458 | -6.377 | -26.1 | 6.164 | 78.55 | -24.66 |
Net income 1 | 1.736 | -4.002 | -8.961 | 3.101 | 39.94 | -15.65 |
Net margin | 0.42% | -1.25% | -2.53% | 0.87% | 8.19% | -4.13% |
EPS 2 | 0.005583 | -0.0129 | -0.0288 | 0.009974 | 0.1285 | -0.0503 |
Free Cash Flow 1 | 6.866 | -106.6 | 36.29 | 0.203 | 63.65 | 41.83 |
FCF margin | 1.67% | -33.22% | 10.26% | 0.06% | 13.06% | 11.02% |
FCF Conversion (EBITDA) | 14.03% | - | - | 1.1% | 71.19% | 2,283.2% |
FCF Conversion (Net income) | 395.51% | - | - | 6.55% | 159.35% | - |
Dividend per Share 2 | 0.001676 | - | - | 0.003000 | 0.0386 | - |
Announcement Date | 08/03/19 | 05/03/20 | 10/03/21 | 05/03/22 | 04/03/23 | 08/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 230 | 338 | 315 | 324 | 169 | 164 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 4.702 x | 96.75 x | -41.69 x | 17.48 x | 1.889 x | 89.73 x |
Free Cash Flow 1 | 6.87 | -107 | 36.3 | 0.2 | 63.7 | 41.8 |
ROE (net income / shareholders' equity) | 2.15% | -0.73% | -3.55% | 1.54% | 15% | -5.67% |
ROA (Net income/ Total Assets) | 1.53% | -2.17% | -2.96% | -0.36% | 5.38% | -1.04% |
Assets 1 | 113.5 | 184.7 | 303 | -866.9 | 742.8 | 1,498 |
Book Value Per Share 2 | 0.7700 | 0.7500 | 0.7000 | 0.7000 | 0.8000 | 0.7500 |
Cash Flow per Share 2 | 0.0800 | 0.0700 | 0.1500 | 0.1200 | 0.4400 | 0.2900 |
Capex 1 | 19.1 | 23.8 | 17.1 | 9.16 | 12.7 | 11.2 |
Capex / Sales | 4.65% | 7.42% | 4.82% | 2.56% | 2.6% | 2.96% |
Announcement Date | 08/03/19 | 05/03/20 | 10/03/21 | 05/03/22 | 04/03/23 | 08/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-5.53% | 43.42M | |
+7.99% | 9.6B | |
+17.27% | 8.29B | |
+18.36% | 2.8B | |
+21.05% | 1.83B | |
+1.33% | 1.83B | |
+25.15% | 1.81B | |
+11.71% | 985M | |
-3.75% | 911M | |
+22.58% | 670M |
- Stock Market
- Equities
- NUTRAVALOR Stock
- Financials Inversiones Nutravalor S.A.